Minnesota Jury Awards $65M Cancer Case Against Johnson & Johnson

Core Viewpoint - A Minnesota jury awarded $65.5 million to a plaintiff who claimed Johnson & Johnson's talcum products contributed to her cancer, highlighting ongoing legal challenges for the company regarding the safety of its talc-based products [1][2]. Group 1: Legal Developments - The jury's decision came after a 13-day trial where the plaintiff's legal team argued that Johnson & Johnson knowingly sold talc products that could be contaminated with asbestos [2]. - Johnson & Johnson plans to appeal the verdict, maintaining that its baby powder is safe and does not contain asbestos [3][5]. - This case is part of a broader legal battle, with previous verdicts including a $40 million award to two women for ovarian cancer claims and a $966 million judgment related to mesothelioma [6]. Group 2: Product Safety Claims - Johnson & Johnson's representatives assert that decades of studies support the safety of their baby powder, claiming it does not cause cancer [5]. - The company ceased selling talc-based powder globally in 2023, indicating a shift in its product strategy amid ongoing litigation [4].